Association of a Homologous Recombination Deficiency Signature with Oncologic Outcomes in Advanced Endometrial Cancer
Year: 2026
Type: article
Study design: Observational Study
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Keywords: homologous recombination deficiency, endometrial cancer, prognostic factors, TP53 mutation, molecular subtypes, serous endometrial carcinoma, progression-free survival, overall survival, time to next treatment, comprehensive genomic profiling, real-world outcomes, advanced endometrial cancer, PARP inhibitors, immunotherapy response
Open Access status: closed
OpenAlex ID: W7225014604
